- Research works
- 0 fractional, all time
- Citations
- 5 10.0 per fractional work
- Top-10% rate
- 0.0% all institutions 10.0%
- Open access
- 100% world 40%
Not ranked overall: ImmuVen (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does ImmuVen (United States) work in?
In all years, 60% of research at ImmuVen (United States) is in Health Sciences, 40% in Physical Sciences. Its largest fields are Medicine (60%), Engineering (40%).
Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 2 domains and 2 fields, with their numbers
- Health Sciences060.0%
- Medicine060.0%
- Physical Sciences040.0%
- Engineering040.0%
Which research topics does ImmuVen (United States) publish most on?
By volume: Antimicrobial Resistance in Staphylococcus, Biosensors and Analytical Detection and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
Other research institutions in Champaign
- Illinois Archaeological Survey
- Parkland College
- Wolfram Research (United States)
- Rao Research and Consulting (United States)
- American Dairy Science Association
- Committee on Institutional Cooperation
- CU Aerospace (United States)
- Nuclear Plasma Laboratories (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about ImmuVen (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.